Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

A research team from Helmholtz Munich and the Technical University of Munich has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system ...

An Emirati doctor who found himself on the front lines against Covid-19 in the US during the pandemic is on a mission to ...

The Exosome Research Market is poised for exceptional growth, with an expected surge in market value from US$ 236.99 million in 2024 to an impressive US$ 1,690.88 million by 2033, growing at a robust ...

When Robert Damoiseaux shifted from a career in pharmaceuticals to help launch an open-access technology platform housed at the California NanoSystems ...

The gallbladder plays an important role in digestion but hasn’t received much attention in medical research. However, that’s starting to change. With advances in stem cell technology, scientists can ...

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

Michigan State University researchers developed light-sensitive chemicals to treat breast cancer, proving effective in mice ...